Abstract
Patients presenting with severe burden of disease with either in transit lesions or large, unresectable tumors, limited to a single limb, are generally not considered for surgical resection, as we aim to provide limb-sparing optionsfor treatment. High-dose regional therapy was first described in melanoma in the 1950s using isolated limb perfusion (ILP), a complex, costly, and invasive procedure. Isolated limb infusion (ILI) was developed in the early 1990s to offer a minimally invasive approach with outcomes comparable to ILP. ILI is a technique of low-flow isolated limb chemotherapy infusion via percutaneously placed arterial and venous catheters. In this chapter, we review both the technical and clinical aspects of ILI, from patient selection to long-term follow-up. From a technical standpoint, we will discuss chemotherapy selection, catheter insertion technique, and nuances of the procedure. We will also discuss patient care, includingpreoperative assessment, intraoperative care, postoperative care and follow-up, as well as the indications for repeat ILI procedures.
Original language | English |
---|---|
Title of host publication | Cancer Regional Therapy |
Subtitle of host publication | HAI, HIPEC, HILP, ILI, PIPAC and Beyond |
Publisher | Springer International Publishing |
Pages | 357-366 |
Number of pages | 10 |
ISBN (Electronic) | 9783030288914 |
ISBN (Print) | 9783030288907 |
DOIs | |
State | Published - Jan 1 2019 |
Keywords
- Chemotherapy
- Hyperthermic isolated limb perfusion
- In-transit metastasis
- Isolated limb infusion
- Melanoma
- Regional therapy